Cellana Inc.
- Biotech – food & agriculture
- Biotech – industrial & Environmental
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
Cellana is a leading developer of algae-based products for nutrition and wellness. Following its recent acquisition of PhytoSmart, Cellana and PhytoSmart have launched DHA- and EPA-enriched whole algae products for pet supplement applications, with expansion into human supplements underway. These products are designed to deliver high-quality Omega-3 oils while eliminating reliance on fish-derived sources. With a mission to provide the most sustainable and renewable source of DHA and EPA for both supplement and pharmaceutical applications, Cellana is leveraging proprietary algae cultivation and processing technologies to meet growing demand for plant-based, eco-friendly alternatives in the global Omega-3 market. Longer term, the same algae strains that produce DHA and EPA Omega-3 oils for high-value applications can be scaled up for large-volume food and animal feed applications, representing the most sustainable source of plant-based protein on the planet.